Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction

Glioblastoma represents the most devastating form of human brain cancer, associated with a very poor survival rate of patients. Unfortunately, treatment options are currently limited and the gold standard pharmacological treatment with the chemotherapeutic drug temozolomide only slightly increases t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marc Dahlmanns, Eduard Yakubov, Jana Katharina Dahlmanns
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
xCT
Acceso en línea:https://doaj.org/article/85a6ad0a3cb8479790113f87b4c61a31
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:85a6ad0a3cb8479790113f87b4c61a31
record_format dspace
spelling oai:doaj.org-article:85a6ad0a3cb8479790113f87b4c61a312021-12-01T22:17:40ZGenetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction2234-943X10.3389/fonc.2021.783067https://doaj.org/article/85a6ad0a3cb8479790113f87b4c61a312021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.783067/fullhttps://doaj.org/toc/2234-943XGlioblastoma represents the most devastating form of human brain cancer, associated with a very poor survival rate of patients. Unfortunately, treatment options are currently limited and the gold standard pharmacological treatment with the chemotherapeutic drug temozolomide only slightly increases the survival rate. Experimental studies have shown that the efficiency of temozolomide can be improved by inducing ferroptosis – a recently discovered form of cell death, which is different from apoptosis, necrosis, or necroptosis and, which is characterized by lipid peroxidation and reactive oxygen species accumulation. Ferroptosis can also be activated to improve treatment of malignant stages of neuroblastoma, meningioma, and glioma. Due to their role in cancer treatment, ferroptosis-gene signatures have recently been evaluated for their ability to predict survival of patients. Despite positive effects during chemotherapy, the drugs used to induce ferroptosis – such as erastin and sorafenib – as well as genetic manipulation of key players in ferroptosis – such as the cystine-glutamate exchanger xCT and the glutathione peroxidase GPx4 – also impact neuronal function and cognitive capabilities. In this review, we give an update on ferroptosis in different brain tumors and summarize the impact of ferroptosis on healthy tissues.Marc DahlmannsEduard YakubovJana Katharina DahlmannsFrontiers Media S.A.articleferroptosisneuroblastomaglioblastomaerastinneuronxCTNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic ferroptosis
neuroblastoma
glioblastoma
erastin
neuron
xCT
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle ferroptosis
neuroblastoma
glioblastoma
erastin
neuron
xCT
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Marc Dahlmanns
Eduard Yakubov
Jana Katharina Dahlmanns
Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction
description Glioblastoma represents the most devastating form of human brain cancer, associated with a very poor survival rate of patients. Unfortunately, treatment options are currently limited and the gold standard pharmacological treatment with the chemotherapeutic drug temozolomide only slightly increases the survival rate. Experimental studies have shown that the efficiency of temozolomide can be improved by inducing ferroptosis – a recently discovered form of cell death, which is different from apoptosis, necrosis, or necroptosis and, which is characterized by lipid peroxidation and reactive oxygen species accumulation. Ferroptosis can also be activated to improve treatment of malignant stages of neuroblastoma, meningioma, and glioma. Due to their role in cancer treatment, ferroptosis-gene signatures have recently been evaluated for their ability to predict survival of patients. Despite positive effects during chemotherapy, the drugs used to induce ferroptosis – such as erastin and sorafenib – as well as genetic manipulation of key players in ferroptosis – such as the cystine-glutamate exchanger xCT and the glutathione peroxidase GPx4 – also impact neuronal function and cognitive capabilities. In this review, we give an update on ferroptosis in different brain tumors and summarize the impact of ferroptosis on healthy tissues.
format article
author Marc Dahlmanns
Eduard Yakubov
Jana Katharina Dahlmanns
author_facet Marc Dahlmanns
Eduard Yakubov
Jana Katharina Dahlmanns
author_sort Marc Dahlmanns
title Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction
title_short Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction
title_full Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction
title_fullStr Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction
title_full_unstemmed Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction
title_sort genetic profiles of ferroptosis in malignant brain tumors and off-target effects of ferroptosis induction
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/85a6ad0a3cb8479790113f87b4c61a31
work_keys_str_mv AT marcdahlmanns geneticprofilesofferroptosisinmalignantbraintumorsandofftargeteffectsofferroptosisinduction
AT eduardyakubov geneticprofilesofferroptosisinmalignantbraintumorsandofftargeteffectsofferroptosisinduction
AT janakatharinadahlmanns geneticprofilesofferroptosisinmalignantbraintumorsandofftargeteffectsofferroptosisinduction
_version_ 1718404110887157760